Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Asymmetrical Dimethylarginine Levels in Hepatitis B Virus-Positive Patients.

Karakecili F, Cikman A, Aydin M, Gulhan B.

Ann Lab Med. 2018 Sep;38(5):446-449. doi: 10.3343/alm.2018.38.5.446.

2.

Lower baseline ALT cut-off values and HBV DNA levels better differentiate HBeAg- chronic hepatitis B patients from inactive chronic carriers.

Assy N, Beniashvili Z, Djibre A, Nasser G, Grosovski M, Nseir W.

World J Gastroenterol. 2009 Jun 28;15(24):3025-31.

3.

Relationship between hepatitis B virus DNA levels and liver histology in patients with chronic hepatitis B.

Shao J, Wei L, Wang H, Sun Y, Zhang LF, Li J, Dong JQ.

World J Gastroenterol. 2007 Apr 14;13(14):2104-7.

4.

Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection.

Papatheodoridis GV, Chrysanthos N, Hadziyannis E, Cholongitas E, Manesis EK.

J Viral Hepat. 2008 Jun;15(6):434-41. doi: 10.1111/j.1365-2893.2007.00957.x. Epub 2008 Jan 9.

PMID:
18194171
5.

Level of hepatitis B virus DNA in inactive carriers with persistently normal levels of alanine aminotransferase.

Chu CM, Chen YC, Tai DI, Liaw YF.

Clin Gastroenterol Hepatol. 2010 Jun;8(6):535-40. doi: 10.1016/j.cgh.2010.03.006. Epub 2010 Mar 19.

PMID:
20304099
6.

Positive association between serum apolipoprotein M levels and hepatitis B virus DNA load in HBeAg-negative chronic hepatitis B.

Shen T, Wu WM, Du WH, Wang L, He G, Tan L, Wang Z, Chen R, Hu M, Ren YP.

Lipids Health Dis. 2016 Dec 7;15(1):210.

7.

Serum galectin-3 levels in children with chronic hepatitis B infection and inactive hepatitis B carriers.

Uluca Ü, Şen V, Ece A, Tan İ, Karabel D, Aktar F, Karabel M, Balık H, Güneş A.

Med Sci Monit. 2015 May 13;21:1376-80. doi: 10.12659/MSM.894035.

8.

Role of hepatitis B surface antigen (HBsAg) in identifying true inactive HBsAg carriers infected with genotype C hepatitis B virus.

Yim SY, Um SH, Jung JY, Seo YS, Yim HJ, Ryu HS, Chun HJ, Jeen YT, Kim CD, Keum B, Lee HS.

J Clin Gastroenterol. 2014 Feb;48(2):166-71. doi: 10.1097/MCG.0b013e3182a4711d.

PMID:
24045280
9.

Clinical analysis of patients suffering from chronic hepatitis B superinfected with other hepadnaviruses.

Fu J, Guo D, Gao D, Huang W, Li Z, Jia B.

J Med Virol. 2016 Jun;88(6):1003-9. doi: 10.1002/jmv.24417. Epub 2015 Nov 18.

PMID:
26509653
10.

[Serum ALT and HBV DNA levels in patients with HBeAg-negative chronic hepatitis B].

Kim KH, Na IH, Cha JM, Cho YK, Park SY, Kim HP, Song CS, Heo J, Cho M.

Taehan Kan Hakhoe Chi. 2003 Dec;9(4):284-92. Korean.

PMID:
14695695
11.

Are serum quantitative hepatitis b surface antigen levels, liver histopathology and viral loads related in chronic hepatitis b-infected patients?

Balkan A, Namiduru M, Balkan Y, Mete AO, Karaoglan I, Bosnak VK.

Saudi J Gastroenterol. 2016 May-Jun;22(3):208-14. doi: 10.4103/1319-3767.182454.

12.

IL28B is associated with outcomes of chronic HBV infection.

Shi X, Chi X, Pan Y, Gao Y, Li W, Yang C, Zhong J, Xu D, Zhang M, Minuk G, Jiang J, Niu J.

Yonsei Med J. 2015 May;56(3):625-33. doi: 10.3349/ymj.2015.56.3.625.

13.

Hepatitis B surface antigen levels during natural history of chronic hepatitis B: a Chinese perspective study.

Zeng LY, Lian JS, Chen JY, Jia HY, Zhang YM, Xiang DR, Yu L, Hu JH, Lu YF, Zheng L, Li LJ, Yang YD.

World J Gastroenterol. 2014 Jul 21;20(27):9178-84. doi: 10.3748/wjg.v20.i27.9178.

14.

Treatment with telbivudine positively regulates antiviral immune profiles in Chinese patients with chronic hepatitis B.

Ma L, Cai YJ, Yu L, Feng JY, Wang J, Li C, Niu JQ, Jiang YF.

Antimicrob Agents Chemother. 2013 Mar;57(3):1304-11. doi: 10.1128/AAC.02181-12. Epub 2012 Dec 28.

15.

[Can HBsAg levels guide to differentiate inactive HBsAg carriers from HBeAg negative chronic B hepatitis?].

Sayan M, Mutlu B, Erdoğan S, Meriç M, Willke A.

Mikrobiyol Bul. 2007 Jan;41(1):87-93. Turkish.

PMID:
17427556
16.

IL-35 expression in peripheral blood CD4(+) T cells from chronic hepatitis B virus-infected patients directly correlates with virus load.

Zhou Y, Zhang H, Li Y.

Cytokine. 2015 May;73(1):169-75. doi: 10.1016/j.cyto.2015.02.003. Epub 2015 Mar 6.

PMID:
25752977
17.

Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.

Martinot-Peignoux M, Lapalus M, Laouénan C, Lada O, Netto-Cardoso AC, Boyer N, Ripault MP, Carvalho-Filho R, Asselah T, Marcellin P.

J Clin Virol. 2013 Oct;58(2):401-7. doi: 10.1016/j.jcv.2013.08.010. Epub 2013 Aug 16.

PMID:
24004660
18.

Clinical significance of hepatitis B virus precore and core promoter variants in Korean patients with chronic hepatitis B.

Yim SY, Um SH, Young Jung J, Kim TH, Kim JD, Keum B, Seo YS, Yim HJ, Jeen YT, Lee HS, Chun HJ, Kim CD, Ryu HS.

J Clin Gastroenterol. 2015 Jan;49(1):61-8. doi: 10.1097/MCG.0000000000000052.

PMID:
24406435
19.

Long-term outcome of inactive and active, low viraemic HBeAg-negative-hepatitis B virus infection: Benign course towards HBsAg clearance.

Oliveri F, Surace L, Cavallone D, Colombatto P, Ricco G, Salvati N, Coco B, Romagnoli V, Gattai R, Salvati A, Moriconi F, Yuan Q, Bonino F, Brunetto MR.

Liver Int. 2017 Nov;37(11):1622-1631. doi: 10.1111/liv.13416. Epub 2017 Apr 18.

PMID:
28296013
20.

Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare.

Han Y, Tang Q, Zhu W, Zhang X, You L.

J Gastroenterol Hepatol. 2008 Nov;23(11):1728-33. doi: 10.1111/j.1440-1746.2008.05600.x. Epub 2008 Sep 24.

PMID:
18823435

Supplemental Content

Support Center